Cargando…

Eribulin in Cancer Treatment

Halichondrin B is a complex, natural, polyether macrolide derived from marine sponges. Eribulin is a structurally-simplified, synthetic, macrocyclic ketone analogue of Halichondrin B. Eribulin was approved by United States Food and Drug Administration in 2010 as a third-line therapy for metastatic b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swami, Umang, Shah, Umang, Goel, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557013/ https://www.ncbi.nlm.nih.gov/pubmed/26262627 http://dx.doi.org/10.3390/md13085016

Ejemplares similares

Cancer immunotherapy: recent advances and challenges
por: Swami, Umang, et al.
Publicado: (2021)

Clinical Evidence and Selecting Patients for Treatment with Erdafitinib in Advanced Urothelial Carcinoma
por: Sayegh, Nicolas, et al.
Publicado: (2022)

Harnessing DNA Replication Stress for Novel Cancer Therapy
por: Zhu, Huanbo, et al.
Publicado: (2020)

Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
por: Rathi, Nityam, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Prostate Cancer
por: Venkatachalam, Shobi, et al.
Publicado: (2021)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

Current status of intralesional agents in treatment of malignant melanoma
por: Zawit, Misam, et al.
Publicado: (2021)

The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice
por: Gebrael, Georges, et al.
Publicado: (2023)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review
por: Greco, Austin, et al.
Publicado: (2019)

Clinical Challenges with Talimogene Laherparepvec: Cured Lymph Nodes Masquerading as Active Melanoma
por: Swami, Umang, et al.
Publicado: (2019)

Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function
por: Tan, Antoinette R., et al.
Publicado: (2015)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer
por: Rathi, Nityam, et al.
Publicado: (2020)

Eribulin drug review
por: Shetty, Nishitha, et al.
Publicado: (2014)

The dark side of immunotherapy
por: Okwundu, Nwanneka, et al.
Publicado: (2021)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy
por: Doherty, Mark K, et al.
Publicado: (2015)

Advances in the treatment of soft tissue sarcoma: focus on eribulin
por: Koliou, Panagiotis, et al.
Publicado: (2018)

Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events
por: Swami, Umang, et al.
Publicado: (2019)

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
por: Muñoz-Couselo, Eva, et al.
Publicado: (2011)

Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
por: Yuan, Peng, et al.
Publicado: (2021)

Intraperitoneal seeding of a testicular mixed germ cell tumor following spontaneous intraperitoneal mass rupture with associated anti-NMDA paraneoplastic encephalitis
por: Marshall, Morgan B., et al.
Publicado: (2023)

Eribulin for Advanced Breast Cancer: A Drug Evaluation
por: Shablak, Alaaeldin
Publicado: (2013)

How transparency modulates trust in artificial intelligence
por: Zerilli, John, et al.
Publicado: (2022)

Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research Findings
por: Kok, Victor C.
Publicado: (2015)

Efficacy of eribulin in breast cancer: a short report on the emerging new data
por: Eslamian, Gelareh, et al.
Publicado: (2017)

A randomized trial of eribulin monotherapy versus eribulin plus anlotinib in patients with locally recurrent or metastatic breast cancer
por: Liu, B., et al.
Publicado: (2023)

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas
por: Monga, Varun, et al.
Publicado: (2018)

Favipiravir: A new and emerging antiviral option in COVID-19
por: Agrawal, Umang, et al.
Publicado: (2020)

Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
por: Garrone, Ornella, et al.
Publicado: (2016)

Pearls and paradigms in Infective Keratitis
por: Acharya, Manisha, et al.
Publicado: (2019)

Acute graft rejection in a COVID-19 patient: Co-incidence or causal association?
por: Singh, Garima, et al.
Publicado: (2021)

Leveraging deep learning for COVID-19 diagnosis through chest imaging
por: Khurana, Yashika, et al.
Publicado: (2022)

Cardiac aspergillosis in a patient with chronic granulomatous disease
por: Arora, Umang, et al.
Publicado: (2020)

Utility of Three-Dimensional and Four-Dimensional Transesophageal Echocardiography in Decision-Making in a Patient with Iatrogenic Left Ventricle–to–Right Atrium Shunt (Gerbode Defect)
por: Gupta, Umang, et al.
Publicado: (2023)

Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide
por: Ro, Jungsil, et al.
Publicado: (2016)

Novel approaches for stability improvement in natural medicines
por: Thakur, Lovely, et al.
Publicado: (2011)

Case Studies in the Management of Metastatic Breast Cancer with Eribulin
por: Wilks, Sharon, et al.
Publicado: (2015)

In vitro radiosensitization by eribulin in human cancer cell lines
por: Benlloch, Raquel, et al.
Publicado: (2022)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q3s3fpdgm4oqcvela4kuogg1ku